US FDA Pediatric Priority Review Voucher Renewal May Come With Strings Attached

Legislation to allow the US FDA to continue awarding pediatric rare disease PRVs is moving forward, but has become the subject of partisan disagreements amid calls for new mandatory study authorities to “balance” the program.